Effects of oral thalidomide on rat liver and skin microsomal P450 isozyme activities and on urinary porphyrin excretion: interaction with oral hexachlorobenzene-Reference-Cited by-同舟云学术

Effects of oral thalidomide on rat liver and skin microsomal P450 isozyme activities and on urinary porphyrin excretion: interaction with oral hexachlorobenzene

Published:1994-07 Issue:6 Volume:286 Page:347-349
ISSN:0340-3696
Container-title:Archives of Dermatological Research
language:en
Short-container-title:Arch Dermatol Res

Author:

Tsambaos D.,Bolsen K.,Georgiou S.,Monastirli A.,Goerz G.

Publisher

Springer Science and Business Media LLC

Subject

Dermatology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF00402227.pdf

Reference25 articles.

1. Braun AG, Harding FA, Weinreb SL (1986) Teratogen metabolism: thalidomide activation is mediated by cytochrome P-450. Toxicol Appl Pharmacol 82: 175?179

2. Burrows NP, Walport MJ, Hammond AH, Davey N, Russell Jones R (1991) Lupus erythematosus profundus with partial C4 deficiency responding to thalidomide. Br J Dermatol 125: 62?67

3. Doss M, Schmidt A (1971) Rapid determination of urinary total porphyrins by ion exchange chromatography. Z Klin Biochem 9: 415?418

4. Doss M, Schermuly E, Koss G (1976) Hexachlorobenzene porphyria in rats as a model for human chronic porphyrias. Ann Clin Res 8 [Suppl 17]: 171?181

5. Goerz G, Lissner R (1987) Die Hexachlorobenzol (HCB)-Porphyrie. Zentralbl Haut 153: 505?524

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug-disease interactions of differentially expressed genes in COVID-19 liver samples: an in-silico analysis;Investigación Clínica;2021-11-29

2. Thalidomide Increases Human Hepatic Cytochrome P450 3A Enzymes by Direct Activation of the Pregnane X Receptor;Chemical Research in Toxicology;2014-02-05

3. Cutaneous porphyrias part II: treatment strategies;International Journal of Dermatology;2013-10-18

4. Thalidomide in multiple myeloma – clinical trials and aspects of drug metabolism and toxicity;Expert Opinion on Drug Metabolism & Toxicology;2008-07

5. Potentiation of cyclophosphamide chemotherapy using the anti-angiogenic drug thalidomide: Importance of optimal scheduling to exploit the ‘normalization’ window of the tumor vasculature;Cancer Letters;2006-11